Conversational AI SaaS Solution to Support Cancer Clinical Trials

Belong.Life has officially launched Tara, a SaaS-based conversational AI cancer clinical trial matching platform for health providers and contract research organizations (CROs). According to the company, Tara is designed to accelerate the process of matching patients with eligible clinical trials, enabling increased recruitment at significantly lower costs. Following the launch of Dave, Tara is Belong’s second AI Health Mentor suite of solutions.

“Since our founding, Belong has provided clinical trial matching services to more than 30,000 patients,” said Eliran Malki, CEO, co-founder, Belong.Life, in a company press release. “Tara is a natural extension of our services, helping to optimize clinical trial matching to benefit stakeholders with increased patient recruitment, improved randomization, and reduced costs and logistical challenges. Tara will enable more patients around the world to access clinical trials.”

Continue Reading >

More Articles

Equiva to integrate Belong.Life’s AI health mentors

US-based Equiva and Belong.Life have entered a partnership for the integration of the latter’s conversational…

Belong.Life and Equiva bring AI mentors to healthcare providers

Belong.life, the GenAI patient engagement solution, has announced a strategic partnership with Equiva, a US-based digital…

Conversational AI Partnership Expands Access for Equiva and Belong.Life

Revolutionizing Patient Care Through Conversational AI Integration Imagine having a reliable guide by your side…
Skip to content